SARS-CoV-2 Variants and Vaccines

Authors :: Soumya Swaminathan
Marion Gruber
Michael J. Ryan
Philip R. Krause
Valerie Beral
Rogerio Gaspar
Richard Peto
David L Heymann
Alba-Maria Ropero
Jerome Amir Singh
Ran D. Balicer
Maria D. Van Kerkhove
Ana-Maria Henao-Restrepo
Jakob P. Cramer
Ira M. Longini
Sylvie Briand
Thomas R. Fleming
Kanta Subbarao
César Muñoz-Fontela
Matthew D. Snape
Helen Rees
Source :: The New England Journal of Medicine
Publication Year :: 2021
Publisher :: Massachusetts Medical Society, 2021.
Abstract: Summary Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.